Watch now (4 min) | Equally worrying, “cardiovascular manifestations were found in 29.24% of patients”.
When Pfizer and Moderna sought full FDA approval, they received a Biologics License Agreement (BLA) letter from the FDA, which basically said, “You must study myocarditis with your vaccines.”
What this entails, Dr. Peter McCullough explained, is prospective cohort studies, meaning they measure everything (troponin levels, EKG, echocardiogram, ultrasound, etc.) at the beginning, give the vaccine, and compare the results of ‘before and after.
But surprise, surprise, they never did these studies.
However, Mansanguan and colleagues in Thailand did, and the data is alarming.
Their study had a total of 301 children between the ages of 13 and 18. They examined each person’s cardiovascular baseline using troponin levels, EKGs, echocardiograms, heart scans, etc., gave two doses of the Pfizer vaccine, and repeated everything afterwards.
“And here’s the bomb.”
They reached a suspicion rate of myopericarditis of 2.33%.
• “Seven participants (2.33%) showed at least one elevated cardiac biomarker or positive laboratory evaluations.”
• Just as worrying, “Cardiovascular manifestations were found in 29.24% of patientsranging from tachycardia or palpitations to myopericarditis.
• “Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis.”
“This is [23,300] cases per million!” exclaimed Dr. McCullough.
Video and more in the direct link.
English 
Español de Venezuela